Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.067 | 0.2 |
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |